Overview

Gender

male

Gary Loeb was appointed as Executive Vice President and General Counsel of Sangamo Therapeutics in 2019. Prior to Sangamo Therapeutics, he joined Achaogen in 2016 after more than 15 years of legal affairs experience related to intellectual property, corporate governance, compliance, and business development in the biotechnology industry. Mr. Loeb has been General Counsel and Corporate Secretary and on the executive team at three life sciences companies, Amyris, Inc., Counsyl, and Sano Intelligence. He spent eleven years at Genentech as Vice President, Intellectual Property, where he oversaw 90 employees in the areas of litigation, patent prosecution, corporate records, and technology licensing.

Gary Loeb received his B.S. and B.A. degrees from Stanford University and his J.D. from Columbia Law School.